| Common Name: | 50/50 PREDILUTED ENGINE COOLANT/ANTIFREEZE, 50/50 READY-TO-USE ANTIFREEZE/COOLAN |
| Manufacturer: | PRESTONE PRODUCTS |
| SDS Revision Date: | 12/6/2018 |
| SDS Format: | GHS-US |
| Item Number(s): | 48RD29, 56MX67 |
| Manufacturer Model Number(s): |
SDS Table of Contents
Click the desired link below to jump directly to that section in the SDS.
PRESTONE(R*)
SDS508
PRESTONE (R*) 50/50 PREDILUTED ENGINE COOLANT/ANTIFREEZE
PRESTONE (R*) 50/50 READY-TO-USE ANTIFREEZE/COOLANT
DATE PREPARED: 12/6/2018
SAFETY DATA SHEET
| 1. PRODUCT AND COMPANY IDENTIFICATION |  |
SDS ID: SDS508
PRODUCT NAME:
PRESTONE (R*) 50/50 PREDILUTED ENGINE COOLANT/ANTIFREEZE
PRESTONE (R*) 50/50 READY-TO-USE ANTIFREEZE/COOLANT
PRODUCT NUMBER:
AF2050M, AF2050ML, AF2050M19, AF2050M200, AF2100, AF2100LCZ, AF2100LD,
AF2100LHR, AF2100LRU, AF2100LT/F, AF2100PL, AF2100RU, AF2100S/F,
AF2100S/FC, AF2100UK, AF2100/GF, AF2100/GFC, AF2100/X, AF2100-1KL/GF,
AF2100-RETRO/F, AF2155/GF, AF2725, AF2725/GF, AF12050M, PDSPLY36-AFAS,
PDSPLY36-AFASB, PDSPLY36-AFBW, PDSPLY36-AFC, PRES01R, PRES04R,
WSS-M97B57-A2, 65077, 71175, 71175/GF, 71175/GFC, 71175/GFC3, 71183,
71217, AF2300/F, AF2400/F, 78213/FC3, 78213/FC, 78213/F, 78205/F, 78205/FC,
78205/FC3
FORMULA NUMBER:
YA-956BY-P50, YA-956BY-P50-B, YA-956BY-P50M, YA-956BY-P50M-B, YA-992-P50
MANUFACTURER:
PRESTONE PRODUCTS
CORPORATION
69 EAGLE RD.
DANBURY, CT 06810
CANADIAN OFFICE:
PRESTONE CANADA
33 MACINTOSH BLVD.
CONCORD, ON L4K 4L5
MEXICO OFFICE:
ASG OPERATIONS MEXICO S. DE R.L. DE C.V.
CARRETERA MEXICO CUAUTITLAN, KILOMETRO 31.5, NAVE
INDUSTRIAL 5,
LOMA BONITA, CUAUTITLAN, MEXICO, 54800
MEDICAL EMERGENCIES AND ALL OTHER INFORMATION PHONE NUMBER:
(888)269-0750 (IN THE US AND CANADA)
01-800-715-4135 (IN MEXICO)
TRANSPORTATION EMERGENCY PHONE NUMBER (CHEMICAL SPILLS AND TRANSPORT
ACCIDENTS ONLY):
CHEMTREC:
1-800-424-9300 (IN THE US AND CANADA)
+1 703 741-5970 (OUTSIDE THE US AND CANADA)
PRODUCT USE: AUTOMOBILE ANTIFREEZE - CONSUMER PRODUCT
RESTRICTIONS ON USE: NONE IDENTIFIED
| 2. HAZARDS IDENTIFICATION | |
GHS/HAZCOM 2012 CLASSIFICATION:
HEALTH:
ACUTE TOXICITY CATEGORY 4 (ORAL)
SPECIFIC TARGET ORGAN TOXICITY - REPEATED EXPOSURE CATEGORY 2
TOXIC TO REPRODUCTION CATEGORY 2
PHYSICAL: NOT HAZARDOUS
LABEL ELEMENTS:
EXCLAMATION MARK
HEALTH HAZARD
WARNING!
H302: HARMFUL IF SWALLOWED.
H361D: SUSPECTED OF DAMAGING THE UNBORN CHILD.
H373: MAY CAUSE DAMAGE TO KIDNEYS THROUGH PROLONGED OR REPEATED EXPOSURE.
PREVENTION:
P201: OBTAIN SPECIAL INSTRUCTIONS BEFORE USE.
P202:
DO NOT HANDLE UNTIL ALL SAFETY PRECAUTIONS HAVE BEEN READ AND UNDERSTOOD.
P260: DO NOT BREATHE MIST OR VAPORS.
P264: WASH EXPOSED SKIN THOROUGHLY AFTER HANDLING.
P270: DO NOT EAT, DRINK, OR SMOKE WHEN USING THIS PRODUCT.
P280: WEAR PROTECTIVE GLOVES.
RESPONSE:
P301 + P312:
IF SWALLOWED: CALL A POISON CENTER OR PHYSICIAN IF YOU FEEL UNWELL.
P330: RINSE MOUTH.
P308 + P313:
IF EXPOSED OR CONCERNED: GET MEDICAL ADVICE.
DISPOSAL:
P405: STORE LOCKED UP.
P501:
DISPOSE OF CONTENTS AND CONTAINER IN ACCORDANCE WITH LOCAL AND NATIONAL
REGULATIONS.
| 3. COMPOSITION/INFORMATION ON INGREDIENTS | |
COMPONENT CAS NO. AMOUNT
ETHYLENE GLYCOL 107-21-1 30-60
WATER 7732-18-5 30-60
DIETHYLENE GLYCOL 111-46-6 0-5
2-ETHYL HEXANOIC ACID, SODIUM SALT 19766-89-3 0-5
THE EXACT CONCENTRATIONS ARE A TRADE SECRET.
| 4. FIRST AID MEASURES | |
INHALATION:
REMOVE THE VICTIM TO FRESH AIR. IF BREATHING HAS STOPPED ADMINISTER
ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, HAVE MEDICAL PERSONNEL
ADMINISTER OXYGEN. GET MEDICAL ATTENTION.
SKIN CONTACT:
REMOVE CONTAMINATED CLOTHING. IMMEDIATELY WASH CONTACTED AREA THOROUGHLY
WITH SOAP AND WATER. IF IRRITATION PERSISTS, GET MEDICAL ATTENTION.
EYE CONTACT:
IMMEDIATELY FLUSH EYES WITH LARGE AMOUNTS OF WATER FOR 15 MINUTES. GET
MEDICAL ATTENTION IF IRRITATION PERSISTS.
INGESTION:
SEEK IMMEDIATE MEDICAL ATTENTION. IMMEDIATELY CALL LOCAL POISON CONTROL
CENTER OR GO TO AN EMERGENCY DEPARTMENT. NEVER GIVE ANYTHING BY MOUTH TO
OR INDUCE VOMITING IN AN UNCONSCIOUS OR DROWSY PERSON.
MOST IMPORTANT SYMPTOMS:
MAY CAUSE EYE IRRITATION. INHALATION OF MISTS MAY CAUSE NOSE AND THROAT
IRRITATION AND NERVOUS SYSTEM EFFECTS. INGESTION MAY CAUSE ABDOMINAL
DISCOMFORT OR PAIN, NAUSEA, VOMITING, DIZZINESS, DROWSINESS, MALAISE,
BLURRING OF VISION, IRRITABILITY, BACK PAIN, DECREASE IN URINE OUTPUT,
KIDNEY FAILURE, AND CENTRAL NERVOUS SYSTEM EFFECTS.
INDICATION OF IMMEDIATE MEDICAL ATTENTION AND SPECIAL TREATMENT, IF NEEDED:
SEEK IMMEDIATE MEDICAL ATTENTION FOR LARGE INGESTIONS.
NOTES TO PHYSICIAN:
THE PRINCIPAL TOXIC EFFECTS OF ETHYLENE GLYCOL, WHEN SWALLOWED, ARE KIDNEY
DAMAGE AND METABOLIC ACIDOSIS. THE COMBINATION OF METABOLIC ACIDOSIS, AN
OSMOL GAP AND OXALATE CRYSTALS IN THE URINE IS EVIDENCE OF ETHYLENE GLYCOL
POISONING. PULMONARY EDEMA WITH HYPOXEMIA HAS BEEN DESCRIBED IN A NUMBER OF
PATIENTS FOLLOWING POISONING WITH ETHYLENE GLYCOL. RESPIRATORY SUPPORT WITH
MECHANICAL VENTILATION MAY BE REQUIRED. THERE MAY BE CRANIAL NERVE
INVOLVEMENT IN THE LATE STAGES OF TOXICITY FROM SWALLOWED ETHYLENE GLYCOL.
IN PARTICULAR, EFFECTS HAVE BEEN REPORTED INVOLVING THE SEVENTH, EIGHTH,
AND NINTH CRANIAL NERVES, PRESENTING WITH BILATERAL FACIAL PARALYSIS,
DIMINISHED HEARING AND DYSPHAGIA.
ETHANOL IS ANTIDOTAL AND ITS EARLY ADMINISTRATION MAY BLOCK THE FORMATION
OF NEPHROTOXIC METABOLITES OF ETHYLENE GLYCOL IN THE LIVER. THE OBJECTIVE
IS TO RAPIDLY ACHIEVE AND MAINTAIN A BLOOD ETHANOL LEVEL OF APPROXIMATELY
100 MG/DL BY GIVING A LOADING DOSE OF ETHANOL FOLLOWED BY A MAINTENANCE
DOSE. INTRAVENOUS ADMINISTRATION OF ETHANOL IS THE PREFERRED ROUTE. ETHANOL
BLOOD LEVELS SHOULD BE CHECKED FREQUENTLY. HEMODIALYSIS MAY BE REQUIRED.
4-METHYL PYRAZOLE (FOMEPIZOLE(R*)), A POTENT INHIBITOR OF ALCOHOL
DEHYDROGENASE, HAS BEEN USED THERAPEUTICALLY TO DECREASE THE METABOLIC
CONSEQUENCES OF ETHYLENE GLYCOL POISONING. FOMEPIZOLE(R*) IS EASIER TO USE
CLINICALLY THAN ETHANOL, DOES NOT CAUSE CNS DEPRESSION OR HYPOGLYCEMIA AND
REQUIRES LESS MONITORING THAN ETHANOL. ADDITIONAL THERAPEUTIC MODALITIES
WHICH MAY DECREASE THE ADVERSE CONSEQUENCES OF ETHYLENE GLYCOL METABOLISM
ARE THE ADMINISTRATION OF BOTH THIAMINE AND PYRIDOXINE. AS THERE ARE
COMPLICATED AND SERIOUS OVERDOSES, WE RECOMMEND YOU CONSULT WITH THE
TOXICOLOGISTS AT YOUR POISON CONTROL CENTER.
| 5. FIREFIGHTING MEASURES | |
SUITABLE EXTINGUISHING MEDIA:
USE ANY MEDIA APPROPRIATE FOR THE SURROUNDING FIRE.
SPECIFIC HAZARDS ARISING FROM THE CHEMICAL:
A SOLID STREAM OF WATER OR FOAM DIRECTED INTO HOT, BURNING LIQUID CAN
CAUSE FROTHING. BURNING MAY PRODUCE CARBON MONOXIDE AND CARBON DIOXIDE.
SPECIAL FIRE FIGHTING PROCEDURES:
DO NOT SPRAY POOL FIRES DIRECTLY. FIREFIGHTERS SHOULD WEAR POSITIVE
PRESSURE SELF-CONTAINED BREATHING APPARATUS AND FULL PROTECTIVE CLOTHING
FOR FIRES IN AREAS WHERE CHEMICALS ARE USED OR STORED.
| 6. ACCIDENTAL RELEASE MEASURES | |
PERSONAL PRECAUTIONS, PROTECTIVE EQUIPMENT AND EMERGENCY PROCEDURES:
WEAR APPROPRIATE PROTECTIVE CLOTHING AND EQUIPMENT (SEE SECTION 8).
METHODS AND MATERIALS FOR CONTAINMENT/CLEANUP:
COLLECT WITH ABSORBENT MATERIAL AND PLACE IN APPROPRIATE, LABELED
CONTAINER FOR DISPOSAL OR, IF PERMITTED FLUSH SPILL AREA WITH WATER.
| 7. HANDLING AND STORAGE | |
PRECAUTIONS FOR SAFE HANDLING:
HARMFUL OR FATAL IF SWALLOWED. DO NOT DRINK ANTIFREEZE OR SOLUTION. AVOID
EYE AND PROLONGED OR REPEATED SKIN CONTACT. AVOID BREATHING VAPORS OR
MISTS. WASH EXPOSED SKIN THOROUGHLY WITH SOAP AND WATER AFTER USE. KEEP
CONTAINER AWAY FROM OPEN FLAMES AND EXCESSIVE HEAT. DO NOT REUSE EMPTY
CONTAINERS UNLESS PROPERLY CLEANED. EMPTY CONTAINERS RETAIN PRODUCT
RESIDUE AND MAY BE DANGEROUS. DO NOT CUT, WELD, DRILL, ETC. CONTAINERS,
EVEN EMPTY.
SUDDEN RELEASE OF HOT ORGANIC CHEMICAL VAPORS OR MISTS FROM PROCESS
EQUIPMENT OPERATING AT ELEVATED TEMPERATURE AND PRESSURE, OR SUDDEN INGRESS
OF AIR INTO VACUUM EQUIPMENT, MAY RESULT IN IGNITIONS WITHOUT ANY OBVIOUS
IGNITION SOURCES. PUBLISHED "AUTOIGNITION" OR "IGNITION" TEMPERATURES
CANNOT BE TREATED AS SAFE OPERATING TEMPERATURES IN CHEMICAL PROCESSES
WITHOUT ANALYSIS OF THE ACTUAL PROCESS CONDITIONS. USE OF THIS PRODUCT IN
ELEVATED TEMPERATURE APPLICATIONS SHOULD BE THOROUGHLY EVALUATED TO ASSURE
SAFE OPERATING CONDITIONS.
CONDITIONS FOR SAFE STORAGE, INCLUDING ANY INCOMPATIBILITIES:
DO NOT STORE IN OPENED OR UNLABELED CONTAINERS. STORE AWAY FROM EXCESSIVE
HEAT AND OXIDIZERS.
NFPA CLASSIFICATION:
IIIB (MAY QUALIFY FOR THE FOLLOWING CONSUMER QUANTITY EXEMPTION: CONSUMER
PRODUCTS THAT CONTAIN NOT MORE THAN 50 PERCENT BY VOLUME OF WATER-MISCIBLE
FLAMMABLE OR COMBUSTIBLE LIQUIDS, WITH THE REMAINDER OF THE PRODUCT
CONSISTING OF COMPONENTS THAT DO NOT BURN AND WHERE PACKAGED IN INDIVIDUAL
CONTAINERS THAT DO NOT EXCEED 1.3 GAL (5 L) CAPACITY.)
| 8. EXPOSURE CONTROLS / PERSONAL PROTECTION | |
EXPOSURE GUIDELINES:
CHEMICAL EXPOSURE LIMIT
ETHYLENE GLYCOL 25 PPM TWA, 50 PPM STEL ACGIH TLV (AS VAPOR)
10 MG/M3 TWA ACGIH TLV (AS INHALABLE FRACTION
OF THE AEROSOL)
WATER NONE ESTABLISHED
DIETHYLENE GLYCOL 10 MG/M3 TWA AIHA WEEL
2-ETHYL HEXANOIC ACID NONE ESTABLISHED
APPROPRIATE ENGINEERING CONTROLS:
USE GENERAL VENTILATION OR LOCAL EXHAUST AS REQUIRED TO MAINTAIN EXPOSURES
BELOW THE OCCUPATIONAL EXPOSURE LIMITS.
PERSONAL PROTECTIVE EQUIPMENT:
RESPIRATORY PROTECTION:
FOR OPERATIONS WHERE THE OCCUPATIONAL EXPOSURE LIMIT IS EXCEEDED A NIOSH
APPROVED RESPIRATOR WITH ORGANIC VAPOR CARTRIDGES AND DUST/MIST PREFILTERS
OR SUPPLIED AIR RESPIRATOR IS RECOMMENDED. EQUIPMENT SELECTION DEPENDS ON
CONTAMINANT TYPE AND CONCENTRATION. SELECT AND USE IN ACCORDANCE WITH
29 CFR 1910.134 AND GOOD INDUSTRIAL HYGIENE PRACTICE. FOR FIREFIGHTING,
USE SELF-CONTAINED BREATHING APPARATUS.
GLOVES:
CHEMICAL RESISTANT GLOVES SUCH AS NEOPRENE OR PVC WHERE CONTACT IS
POSSIBLE.
EYE PROTECTION: SPLASH-PROOF GOGGLES.
OTHER PROTECTIVE EQUIPMENT/CLOTHING:
APPROPRIATE PROTECTIVE CLOTHING AS NEEDED TO MINIMIZE SKIN CONTACT.
| 9. PHYSICAL AND CHEMICAL PROPERTIES | |
APPEARANCE: YELLOW LIQUID
ODOR: CHARACTERISTIC ODOR
ODOR THRESHOLD: NONE
PH: 8.4 - 9.0
MELTING/FREEZING POINT: -34 DEG. F (-36 DEG. C)
BOILING POINT/RANGE: 226-229 DEG. F (108-109 DEG. C)
FLASH POINT: NO FLASH @ >216 DEG. F (>102.2 DEG. C) SCC
EVAPORATION RATE: NOT DETERMINED
FLAMMABILITY (SOLID, GAS): NOT APPLICABLE
FLAMMABILITY LIMITS:
LEL: NOT DETERMINED
UEL: NOT DETERMINED
VAPOR PRESSURE: <0.1 MMHg @ 68 DEG. F
VAPOR DENSITY: NOT DETERMINED
RELATIVE DENSITY: 1.07
SOLUBILITIES:
WATER: COMPLETE"
PARTITION COEFFICIENT (N-OCTANOL/WATER): NOT DETERMINED
AUTOIGNITION TEMPERATURE: NOT DETERMINED
DECOMPOSITION TEMPERATURE: NOT DETERMINED
VISCOSITY: NOT DETERMINED
| 10. STABILITY AND REACTIVITY | |
REACTIVITY: NORMALLY UNREACTIVE
CHEMICAL STABILITY: STABLE
POSSIBILITY OF HAZARDOUS REACTIONS:
REACTION WITH STRONG OXIDIZERS WILL GENERATE HEAT.
CONDITIONS TO AVOID: NONE KNOWN
INCOMPATIBLE MATERIALS:
NORMALLY UNREACTIVE, HOWEVER, AVOID STRONG BASES AT HIGH TEMPERATURES,
STRONG ACIDS, STRONG OXIDIZING AGENTS, AND MATERIALS REACTIVE WITH HYDROXYL
COMPOUNDS.
HAZARDOUS DECOMPOSITION PRODUCTS: CARBON MONOXIDE, CARBON DIOXIDE.
| 11. TOXICOLOGICAL INFORMATION | |
POTENTIAL HEALTH EFFECTS:
ACUTE HAZARDS:
INHALATION:
MAY CAUSE IRRITATION OF THE NOSE AND THROAT WITH HEADACHE, PARTICULARLY
FROM MISTS. HIGH VAPOR CONCENTRATIONS CAUSED, FOR EXAMPLE, BY HEATING THE
MATERIAL IN AN ENCLOSED AND POORLY VENTILATED WORKPLACE, MAY PRODUCE
NAUSEA, VOMITING, HEADACHE, DIZZINESS AND IRREGULAR EYE MOVEMENTS.
SKIN CONTACT: NO EVIDENCE OF ADVERSE EFFECTS FROM AVAILABLE INFORMATION.
EYE CONTACT:
LIQUID, VAPORS OR MIST MAY CAUSE DISCOMFORT IN THE EYE WITH PERSISTENT
CONJUNCTIVITIS, SEEN AS SLIGHT EXCESS REDNESS OR CONJUNCTIVA. SERIOUS
CORNEAL INJURY IS NOT ANTICIPATED.
INGESTION:
MAY CAUSE ABDOMINAL DISCOMFORT OR PAIN, NAUSEA, VOMITING, DIZZINESS,
DROWSINESS, MALAISE, BLURRING OF VISION, IRRITABILITY, BACK PAIN, DECREASE
IN URINE OUTPUT, KIDNEY FAILURE, AND CENTRAL NERVOUS SYSTEM EFFECTS,
INCLUDING IRREGULAR EYE MOVEMENTS, CONVULSIONS AND COMA. CARDIAC FAILURE
AND PULMONARY EDEMA MAY DEVELOP. SEVERE KIDNEY DAMAGE WHICH MAY BE FATAL
MAY FOLLOW THE SWALLOWING OF ETHYLENE GLYCOL. A FEW REPORTS HAVE BEEN
PUBLISHED DESCRIBING THE DEVELOPMENT OF WEAKNESS OF THE FACIAL MUSCLES,
DIMINISHING HEARING, AND DIFFICULTY WITH SWALLOWING, DURING THE LATE STAGES
OF SEVERE POISONING.
CHRONIC EFFECTS:
PROLONGED OR REPEATED INHALATION EXPOSURE MAY PRODUCE SIGNS OF CENTRAL
NERVOUS SYSTEM INVOLVEMENT, PARTICULARLY DIZZINESS AND JERKING EYE
MOVEMENTS. PROLONGED OR REPEATED SKIN CONTACT MAY CAUSE SKIN SENSITIZATION
AND AN ASSOCIATED DERMATITIS IN SOME INDIVIDUALS. ETHYLENE GLYCOL HAS BEEN
FOUND TO CAUSE BIRTH DEFECTS IN LABORATORY ANIMALS. THE SIGNIFICANCE OF
THIS FINDING TO HUMANS HAS NOT BEEN DETERMINED. 2-ETHYL HEXANOIC ACID,
SODIUM SALT IS SUSPECTED OF CAUSING DEVELOPMENTAL EFFECTS BASED ON ANIMAL
DATA.
CARCINOGENICITY LISTING:
NONE OF THE COMPONENTS OF THESE PRODUCTS IS LISTED AS A CARCINOGEN OR
SUSPECTED CARCINOGEN BY IARC, NTP, ACGIH, OR OSHA.
ACUTE TOXICITY VALUES:
ETHYLENE GLYCOL:
LD50 ORAL RAT: 4700 MG/KG
LD50 SKIN RABBIT: 9530 MG/KG
DIETHYLENE GLYCOL:
LD50 ORAL RAT: 12,565 MG/KG
LD50 SKIN RABBIT: 11,890 MG/KG
SIGNIFICANT LABORATORY DATA WITH POSSIBLE RELEVANCE TO HUMAN HEALTH:
ETHYLENE GLYCOL HAS BEEN SHOWN TO PRODUCE DOSE-RELATED TERATOGENIC EFFECTS
IN RATS AND MICE WHEN GIVEN BY GAVAGE OR IN DRINKING WATER AT HIGH
CONCENTRATIONS OR DOSES. ALSO, IN A PRELIMINARY STUDY TO ASSESS THE EFFECTS
OF EXPOSURE OF PREGNANT RATS AND MICE TO AEROSOLS AT CONCENTRATIONS
150, 1,000 AND 2,500 MG/M3 FOR 6 HOURS A DAY THROUGHOUT THE PERIOD OF
ORGANOGENESIS, TERATOGENIC EFFECTS WERE PRODUCED AT THE HIGHEST
CONCENTRATIONS, BUT ONLY IN MICE. THE CONDITIONS OF THESE LATTER
EXPERIMENTS DID NOT ALLOW A CONCLUSION AS TO WHETHER THE DEVELOPMENTAL
TOXICITY WAS MEDIATED BY INHALATION OF AEROSOL, PERCUTANEOUS ABSORPTION OF
ETHYLENE GLYCOL FROM CONTAMINATED SKIN, OR SWALLOWING OF ETHYLENE GLYCOL
AS A RESULT OF GROOMING THE WETTED COAT. IN A FURTHER STUDY, COMPARING
EFFECTS FROM HIGH AEROSOL CONCENTRATION BY WHOLE-BODY OR NOSE-ONLY
EXPOSURE, IT WAS SHOWN THAT NOSE-ONLY EXPOSURE RESULTED IN MATERNAL
TOXICITY (1,000 AND 2,500 MG/M3) AND DEVELOPMENTAL TOXICITY IN WITH MINIMAL
EVIDENCE OF TERATOGENICITY (2,500 MG/M3). THE NO-EFFECTS CONCENTRATION
(BASED ON MATERNAL TOXICITY) WAS 500 MG/M3. IN A FURTHER STUDY IN MICE,
NO TERATOGENIC EFFECTS COULD BE PRODUCED WHEN ETHYLENE GLYCOL WAS APPLIED
TO THE SKIN OF PREGNANT MICE OVER THE PERIOD OF ORGANOGENESIS. THE ABOVE
OBSERVATIONS SUGGEST THAT ETHYLENE GLYCOL IS TO BE REGARDED AS AN ANIMAL
TERATOGEN; THERE IS CURRENTLY NO AVAILABLE INFORMATION TO SUGGEST THAT
ETHYLENE GLYCOL CAUSED BIRTH DEFECTS IN HUMANS. CUTANEOUS APPLICATION OF
ETHYLENE GLYCOL IS INEFFECTIVE IN PRODUCING DEVELOPMENTAL TOXICITY;
EXPOSURE TO HIGH AEROSOL CONCENTRATION IS ONLY MINIMALLY EFFECTIVE IN
PRODUCING DEVELOPMENTAL TOXICITY; THE MAJOR ROUTE FOR PRODUCING
DEVELOPMENTAL TOXICITY IS PERORALLY.
TWO CHRONIC FEEDING STUDIES, USING RATS AND MICE, HAVE NOT PRODUCED ANY
EVIDENCE THAT ETHYLENE GLYCOL CAUSES DOSE-RELATED INCREASES IN TUMOR
INCIDENCE OR A DIFFERENT PATTERN OF TUMORS COMPARED WITH UNTREATED
CONTROLS. THE ABSENCE OF CARCINOGENIC POTENTIAL FOR ETHYLENE GLYCOL HAS
BEEN SUPPORTED BY NUMEROUS INVITRO GENOTOXICITY STUDIES SHOWING THAT IT
DOES NOT PRODUCE MUTAGENIC OR CLASTOGENIC EFFECTS.
IN A STUDY OF WISTAR RATS, ADVERSE DEVELOPMENTAL RESULTS WERE REPORTED AT A
DOSE OF 100 MG / KG OF BODY WEIGHT FOR 2-ETHYL HEXANOIC ACID, SODIUM SALT.
THIS PRODUCT CONTAINS LESS THAN 0.07% TOLYTRIAZOLE WHICH HAS DEMONSTRATES
MUTAGENIC ACTIVITY IN A BACTERIAL TEST SYSTEM. A CORRELATION HAS BEEN
ESTABLISHED BETWEEN MUTAGENIC ACTIVITY AND CARCINOGENIC ACTIVITY FOR MANY
CHEMICALS. TOLYTRIAZOLE HAS NOT BEEN IDENTIFIED AS A CARCINOGEN OR PROBABLE
CARCINOGEN BY NTP, IARC, ACGIH OR OSHA.
| 12. ECOLOGICAL INFORMATION | |
ECOTOXICITY:
ETHYLENE GLYCOL:
LC50 FATHEAD MINNOW: <10,000 MG/L/96 HR
EC50 DAPHNIA MAGNA: 100,000 MG/L/48 HR
BACTERIAL (PSEUDOMONAS PUTIDA): 10,000 MG/L
PROTOZOA (ENTOSIPHON SULCATUM AND URONEMA PARDUCZI; CHATTON-LWOFF):
>10,000 MG/L
ALGAE (MICROCYSTIS AERUGINOSA): 2,000 MG/L
GREEN ALGAE (SCENEDESMUS QUANDRICAUDA): >10,000 MG/L
DIETHYLENE GLYCOL:
LC50 WESTERN MOSQUITOFISH: >32,000 MG/L/96 HR
PERSISTENCE AND DEGRADABILITY:
ETHYLENE GLYCOL IS READILY BIODEGRADABLE (97-100% IN 2-12 DAYS).
DIETHYLENE GLYCOL IS READILY BIODEGRADABLE (>70% IN 19 DAYS).
BIOACCUMULATIVE POTENTIAL:
ETHYLENE GLYCOL:
A BCF OF 10, REPORTED FOR ETHYLENE GLYCOL IN FISH, GOLDEN IDE (LEUCISCUS
IDUS MELANOTUS), AFTER 3 DAYS OF EXPOSURE SUGGESTS THE POTENTIAL FOR
BIOCONCENTRATION IN AQUATIC ORGANISMS IS LOW.
DIETHYLENE GLYCOL:
AN ESTIMATED BCF OF 3 SUGGESTS THE POTENTIAL FOR BIOCONCENTRATION IN
AQUATIC ORGANISMS IS LOW.
MOBILITY IN SOIL:
ETHYLENE GLYCOL AND DIETHYLENE GLYCOL ARE HIGHLY MOBILE IN SOIL.
OTHER ADVERSE EFFECTS: NONE KNOWN
| 13. DISPOSAL CONSIDERATIONS | |
DISPOSE OF PRODUCT IN ACCORDANCE WITH ALL LOCAL, STATE/PROVINCIAL AND
FEDERAL REGULATIONS.
| 14. TRANSPORT INFORMATION | |
U.S. DOT HAZARD CLASSIFICATION:
NOT REGULATED (UNLESS PACKAGE CONTAINS A REPORTABLE QUANTITY)
NOTE:
IF A SHIPMENT OF A REPORTABLE QUANTITY (8,333 LBS/933 GAL.) IN A SINGLE
PACKAGE IS INVOLVED, THE FOLLOWING INFORMATION APPLIES:
PROPER SHIPPING NAME:
RQ, ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (ETHYLENE GLYCOL)
UN NUMBER: UN3082
PACKING GROUP: III
LABELS REQUIRED: CLASS 9
DOT MARINE POLLUTANTS:
THIS PRODUCT DOES NOT CONTAIN MARINE POLLUTANTS AS DEFINED IN 49 CFR 171.8.
IMDG CODE SHIPPING CLASSIFICATION: NOT REGULATED
CANADIAN TDG CLASSIFICATION: NOT REGULATED
| 15. REGULATORY INFORMATION | |
CERCLA SECTION 103:
SPILLS OF THIS PRODUCT OVER THE RQ (REPORTABLE QUANTITY) MUST BE REPORTED
TO THE NATIONAL RESPONSE CENTER. THE RQ FOR THIS PRODUCT, BASED ON THE RQ
FOR ETHYLENE GLYCOL (60% MAXIMUM) OF 5,000 LBS., IS 8,333 LBS. MANY STATES
HAVE MORE STRINGENT RELEASE REPORTING REQUIREMENTS. REPORT SPILLS REQUIRED
UNDER FEDERAL, STATE AND LOCAL REGULATIONS.
EPA SARA 311/312 HAZARD CLASSIFICATION:
CLASSIFIED UNDER OSHA HAZCOM 2012 GHS CLASSIFICATION AS PER SECTION 2 OF
THIS SDS.
EPA SARA 313:
THIS PRODUCT CONTAINS THE FOLLOWING CHEMICALS SUBJECT TO ANNUAL RELEASE
REPORTING REQUIREMENTS UNDER SARA TITLE III, SECTION 313 (40 CFR 372):
ETHYLENE GLYCOL 107-21-1 30-60%
PROTECTION OF STRATOSPHERIC OZONE:
THIS PRODUCT IS NOT KNOWN TO CONTAIN OR TO HAVE BEEN MANUFACTURED WITH
OZONE DEPLETING SUBSTANCES AS DEFINED IN 40 CFR PART 82, APPENDIX A TO
SUBPART A.
CALIFORNIA PROPOSITION 65:
THIS PRODUCT CONTAINS THE FOLLOWING CHEMICALS KNOWN TO THE STATE OF
CALIFORNIA TO CAUSE CANCER OR REPRODUCTIVE TOXICITY (BIRTH DEFECTS):
ETHYLENE GLYCOL 107-21-1 30-60% DEVELOPMENTAL
EPA TSCA INVENTORY:
ALL OF THE COMPONENTS OF THIS MATERIAL ARE LISTED ON OR EXEMPT FROM THE
TOXIC SUBSTANCES CONTROL ACT (TSCA) CHEMICAL SUBSTANCES INVENTORY.
CANADIAN ENVIRONMENTAL PROTECTION ACT:
ALL OF THE INGREDIENTS ARE LISTED ON OR EXEMPT FROM THE CANADIAN DOMESTIC
SUBSTANCES LIST.
EUROPEAN INVENTORY OF EXISTING COMMERCIAL CHEMICAL SUBSTANCES (EINECS):
ALL OF THE INGREDIENTS ARE LISTED ON OR EXEMPT FROM THE EINECS INVENTORY.
JAPAN:
ALL OF THE INGREDIENTS OF THIS PRODUCT ARE LISTED ON OR EXEMPT FROM THE
JAPANESE EXISTING AND NEW CHEMICAL SUBSTANCES (MITI) LIST.
AUSTRALIA:
ALL OF THE INGREDIENTS OF THIS PRODUCT ARE LISTED ON OR EXEMPT FROM THE
AUSTRALIAN INVENTORY OF CHEMICAL SUBSTANCES. THE SODIUM SALT OF
2-ETHYLHEXANOIC ACID IS NOT LISTED ON THE CHEMICAL INVENTORY HOWEVER, IT
IS A REACTION BY PRODUCT OF THE NEUTRALIZATION OF ANTIFREEZE AND THEREFORE
IS EXEMPT.
NEW ZEALAND:
ALL OF THE INGREDIENTS OF THIS PRODUCT ARE LISTED ON OR EXEMPT FROM THE
NEW ZEALAND INVENTORY OF CHEMICALS (NZLOC).
KOREA:
ALL OF THE INGREDIENTS OF THIS PRODUCT ARE LISTED ON OR EXEMPT FROM THE
KOREAN EXISTING CHEMICAL LIST (KECL).
PHILIPPINES:
ALL OF THE INGREDIENTS OF THIS PRODUCT ARE LISTED ON OR EXEMPT FROM THE
PHILIPPINE INVENTORY OF CHEMICAL AND CHEMICAL SUBSTANCE (PICCS)
CHINA:
ALL OF THE INGREDIENTS OF THIS PRODUCT ARE LISTED ON OR EXEMPT FROM THE
INVENTORY OF EXISTING CHEMICAL SUBSTANCE IN CHINA (IECSC).
| 16. OTHER INFORMATION | |
NFPA RATING (NFPA 704):
FIRE 1
HEALTH 2
INSTABILITY 0
REVISION SUMMARY:
SECTION 1: ADD PART NUMBERS.
SDS DATE OF PREPARATION/REVISION: DECEMBER 6, 2018
THIS SDS IS DIRECTED TO PROFESSIONAL USERS AND BULK HANDLERS OF THE
PRODUCT. CONSUMER PRODUCTS ARE LABELED IN ACCORDANCE WITH FEDERAL
HAZARDOUS SUBSTANCES ACT REGULATIONS.
WHILE PRESTONE PRODUCTS CORPORATION BELIEVES THAT THE DATA CONTAINED HEREIN
ARE FACTUAL AND THE OPINIONS EXPRESSED ARE THOSE OF QUALIFIED EXPERTS
REGARDING THE RESULTS OF THE TESTS CONDUCTED, THE DATA ARE NOT TO BE TAKEN
AS A WARRANTY OR REPRESENTATION FOR WHICH PRESTONE PRODUCTS CORPORATION
ASSUMES LEGAL RESPONSIBILITY. THEY ARE OFFERED SOLELY FOR YOUR
CONSIDERATION, INVESTIGATION AND VERIFICATION. ANY USE OF THESE DATA AND
INFORMATION MUST BE DETERMINED BY THE USER TO BE IN ACCORDANCE WITH
APPLICABLE FEDERAL, STATE AND LOCAL LAWS AND REGULATIONS.